ESC Premium Access

Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics

Congress Presentation

About the speaker

Doctor Janet Leeds

South San Francisco (United States of America)
0 follower

5 more presentations in this session

The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy

Speaker: Doctor K. Tsuchida (Niigata, JP)


Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness

Speaker: Doctor N. Ioakeimidis (Athens, GR)


Acute and chronic effect of ticagrelor versus clopidogrel on aortic stiffness

Speaker: Associate Professor C. Vlachopoulos (Athens, GR)


Cilostazol induces regression of carotid plaque in patients with high cardiovascular risk: CLOVER study. A multicenter, randomized trial.

Speaker: Professor K. Cho (Busan, KR)


Ticagrelor reduced CD40L level in patient with ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention compared with clopidogrel

Speaker: Doctor Z. Li (Jinan, CN)


Access the full session

Optimal surrogate endpoints of drug response

Speakers: Doctor J. Leeds, Doctor K. Tsuchida, Doctor N. Ioakeimidis, Associate Professor C. Vlachopoulos, Professor K. Cho...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb